International Biotechnology Trust PLC Sarepta Therapeutics, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 26,700 shares of SRPT stock, worth $3.22 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
26,700
Previous 18,800
42.02%
Holding current value
$3.22 Million
Previous $2.15 Million
50.37%
% of portfolio
1.1%
Previous 0.67%
Shares
17 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.08 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$755 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$526 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$515 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...